Use of scara5 in preparing drugs for promoting repair of odontogenic tissue injury

Through the Scara5-labeled cell subpopulations, the key role of periodontal, pulp and alveolar bone injury repair in odontogenic tissues, the problem of poor repair of odontogenic tissues in the prior art was solved, and the dental source was realized Effective repair of sexual tissue damage.

WO2024230638A1PCT designated stage expired Publication Date: 2024-11-14SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/091181
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-06
Filing Date
2024-05-06
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

The prior art is difficult to effectively explore and promote the rapid healing of odontogenic tissues, especially in the repair of periodontal, pulp and alveolar bone injuries. The lack of effective intervention methods for specific cell subpopulations leads to poor treatment results.

Method used

Scara5 is used as a biomarker of mesenchymal stem cells in odontogenic tissues, and the subpopulation of Scara5+ cells is screened and labeled through single-cell sequencing technology to explore its role in odontogenic tissue injury repair and develop and promote odontogenic tissue injury repair medicine.

Benefits of technology

Through the Scara5-labeled cell subpopulations, it clarifies its important role in periodontal, pulp and alveolar bone injury repair, provides new intervention targets, promotes the repair of odontogenic tissue, and improves periodontal disease and tooth Treatment effects of medullary disease and alveolar bone defect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024091181_14112024_PF_FP_ABST
    Figure CN2024091181_14112024_PF_FP_ABST
Patent Text Reader

Abstract

Provided is the use of Scara5 in preparing drugs for promoting repair of odontogenic tissue injury, belonging to the field of biological medicines. Since a Scara5-labelled cell subpopulation has a specific lineage fate in odontogenic tissue, it is proposed that Scara5 serves as a biomarker for odontogenic tissue mesenchymal stem cells to screen the odontogenic tissue mesenchymal stem cells, and it is further proposed that Scara5 + an odontogenic mesenchymal stem cell subpopulation are used for preparing drugs for repairing odontogenic tissue injury, and particularly are used for preparing stem cell drugs for periodontal diseases, pulp diseases, alveolar bone defects, alveolar bone resorption and alveolar bone necrosis. Thus, exploring cell subpopulations achieving key functions during processes of repairing odontogenic tissue injury provides a new choice for developing new drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Application of Scara5 in the preparation of drugs for promoting the repair of odontogenic tissue damage Technical Field

[0001] The present invention belongs to the field of biomedicine, and particularly relates to the application of Scara5 in the preparation of a drug for promoting the repair of odontogenic tissue damage. Background Art

[0002] The structure of teeth is complex, consisting of a variety of soft and hard tissues interwoven and stacked, communicating and interacting with each other. Healthy dental pulp and periodontal ligament, as the soft tissues of teeth, are the basis of oral functions such as eating, chewing, and pronunciation, and also affect facial beauty. Damage to odontogenic soft tissues will seriously affect the success rate of later implant restorations, the efficiency of orthodontic tooth movement, and periodontal health, causing huge aesthetic, functional, and oral health risks to patients. Alveolar bone, as the supporting tissue of teeth, plays an important role in mechanical response. Therefore, exploring the key factors for the orderly and rapid healing of odontogenic tissues has become an important issue that needs to be urgently addressed in today's oral clinical treatment oriented towards efficiency, health, function, and aesthetics.

[0003] The healing of dental tissue damage is the result of the orderly coordinated action of multiple cells. It is a complex and complete biological process that requires the coordinated interaction and fine regulation of numerous cell types and multiple signaling mechanisms. The participating cell types include: stem cells, osteoblast precursor cells, vascular endothelial cells, inflammatory immune cells, and other supporting cells, as well as transduction systems such as extracellular matrix, exosomes, cytokines, and other secretory factors and cell-to-cell interactions. In the process of tissue damage and repair, what cell types play the main role? What are the specific molecular mechanisms by which they play this role? Taking tissue damage as the starting point, we will conduct in-depth research on the key cell subpopulations and regulatory mechanisms that maintain the balance of tissue formation and remodeling, which will help to find intervention targets for the repair of periodontal-endodontic damage and alveolar bone damage, create possibilities for the development of new drugs, and provide a scientific basis for the research and verification of new materials for medical devices using these seed cells, thus providing a new way to reshape the treatment of periodontal disease.

[0004] Due to technical limitations, previous studies have mostly been able to investigate the function of a single gene, and have been unable to analyze specific cell subpopulations expressing a particular gene. For example, knockout of key osteogenesis genes such as BSP and PTHrP can lead to poor socket healing, but it remains unclear whether BSP specifically defines the nature of these cells. The emergence of single-cell sequencing (scRNA-seq) has overcome the bottlenecks of existing technologies, enabling precise clustering of individual cells based on their transcriptomes and distinguishing specific functional cell subpopulations from all cells through gene expression. With the support of single-cell sequencing technology, it has become possible to screen and identify cell subpopulations and study their lineage development and fate in specific environments.

[0005] Lineage tracing technology allows the use of key genes to mark and identify single cells and all their progeny, and is an excellent tool for in-depth study of cell differentiation lineages under specific interventions. + The discovery of BMSCs subpopulations provides an important research target for osteogenic differentiation in acute myeloid leukemia. + Islet cell subsets have successfully regenerated pancreatic tissue in vitro and treated diabetic mice. By exploring the key cell subsets, key molecules, and regulatory networks that dominate alveolar bone damage, we aim to find new intervention targets and further develop new drugs and treatment strategies to promote the repair of odontogenic tissue damage.

[0006] Summary of the Invention

[0007] In response to the deficiencies in the prior art, the first aspect of the present invention is to provide the application of Scara5 as a biomarker of dental mesenchymal stem cells, particularly in the preparation of a marker for dental mesenchymal stem cells. Scara5 is specifically expressed in dental mesenchymal stem cells.

[0008] Preferably, the odontogenic tissue includes periodontium, dental pulp and alveolar bone.

[0009] The second aspect of the present invention is to provide a Scara5+ dental mesenchymal stem cell subpopulation, which is obtained by sorting dental tissue cells to obtain cells positive for the Scara5 marker.

[0010] The third aspect of the present invention is to provide the use of the Scara5+ dental mesenchymal stem cell subset in the preparation of a drug for promoting the repair of dental tissue damage.

[0011] Preferably, the odontogenic tissue damage includes periodontal ligament damage, dental pulp damage and alveolar bone damage.

[0012] The fourth aspect of the present invention is the use of dental mesenchymal stem cells specifically expressing Scara5 in the preparation of a drug for promoting the repair of dental tissue damage.

[0013] Preferably, the odontogenic tissue damage includes periodontal ligament damage, dental pulp damage and alveolar bone damage.

[0014] The fifth aspect of the present invention is to provide the use of the Scara5+ dental mesenchymal stem cell subset in the preparation of stem cell drugs for periodontal disease, pulp disease, alveolar bone defect, alveolar bone resorption, and alveolar bone necrosis.

[0015] Compared to the prior art, the present invention discovered that Scara5 is specifically expressed in dental mesenchymal stem cells, thereby proposing the use of Scara5 as a biomarker for dental mesenchymal stem cells, particularly for the preparation of a marker for dental mesenchymal stem cells. Furthermore, Scara5 can be used to prepare drugs that promote mesenchymal stem cell-mediated repair of dental tissue damage, and mesenchymal stem cells that specifically express Scara5 can be used to prepare drugs that promote repair of dental tissue damage. By exploring the key cell subpopulations that dominate dental tissue damage, this provides new options for the development of new drugs that promote the repair of dental tissue damage. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 is a key subpopulation discovered in the human periodontal ligament single-cell atlas in the embodiment; A: Single-cell sequencing UMAP analysis shows the clustering of human periodontal ligament cells; B: Single-gene UMAP diagram shows the expression levels of representative marker genes of known periodontal ligament cell types, with colors ranging from blue to red, indicating relative gene expression levels from low to high, and the Vlin diagram shows the expression level of the gene in each cell type; C: Three-dimensional spatial display of the human periodontal ligament single-cell atlas; D: Cell type enrichment gene heat map; each column represents a cell type, each row represents a signature gene, and colors from purple to yellow indicate relative gene expression levels from low to high; E: UMAP diagram shows the expression levels of individual genes.

[0017] Figure 2 shows the expression marker gene Scara5 of cluster 9 in the embodiment; A: Coloring diagram of the subcluster marker gene Scara5, where colors from gray to red represent relative gene expression levels from low to high; B: Vlin diagram showing the expression level of the gene in each cell type; C: Immunohistochemical staining of Scara5 in human teeth and periodontal supporting tissues; D: Immunohistochemical staining of Scara5 in mouse teeth and periodontal supporting tissues.

[0018] Figure 3 shows the single-cell sequencing analysis in the embodiment, which shows that Scara5 + The cell subpopulation may be the direct precursor cells of periodontal ligament tissue fibroblasts; A: Monocle 2 analysis of fibroblast population and Scara5 + Developmental trajectories of cell subpopulations; B: Pseudo-time series showing the time trajectory from dark blue to light blue (right figure); C: Prediction of the differentiation trajectory of each subpopulation along the time axis.

[0019] Figure 4 shows H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse construction and verification; A: Scara5 gene editing was performed using CRISPR / Cas9 technology to construct Scara5-Cre ERT2Mouse; B: Scara5-Cre ERT2 Mouse identification strategy; C: Scara5-Cre ERT2 Mouse genotype identification electrophoresis diagram; D: Scara5-Cre ERT2 Mouse genotype identification and sequencing results; E: H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse tamoxifen induction strategy; F: H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse Scara5 + Cell expression verification.

[0020] Figure 5 shows H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse lineage tracing experiments have preliminarily shown that Scara5 + The cells expressed less in tissues throughout the body; A: 35 days after induction, the cells expressed in the heart (a1), kidney (a2), liver (a3), lung (a4), spleen (a5) and thymus (a6), and specifically in odontogenic tissues.

[0021] Figure 6 shows H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse lineage tracing experiments showed that Scara5 + Cells are involved in the renewal of odontogenic tissue and the maintenance of homeostasis; A: Section of the first molar on the 3rd day after induction, the boxed areas are magnified in (a1), (a2), (a3) ​​and (a4), respectively; B: Section of the first molar on the 7th day after induction, the boxed areas are magnified in (b1), (b2), (b3) and (b4), respectively; C: Section of the first molar on the 60th day after induction, the boxed areas are magnified in (c1), (c2), (c3) and (c4), respectively.

[0022] Figure 7 shows H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse lineage tracing experiments have preliminarily shown that Scara5 +Cells promote the repair of periodontal-alveolar bone damage; A: The damaged side of the maxillary first molar 14 days after induction, the boxed areas are magnified in (a1), (a2), (a3) ​​and (a4) respectively; B: Sections of the control side of the maxillary first molar 14 days after induction, the boxed areas are magnified in (b1), (b2), (b3) and (b4) respectively; C: Sections of the damaged side of the maxillary first molar 30 days after induction, the boxed areas are magnified in (c1), (c2), (c3) and (c4) respectively; D: Sections of the control side of the maxillary first molar 30 days after induction, the boxed areas are magnified in (d1), (d2), (d3) and (d4) respectively.

[0023] Figure 8 shows H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Mouse lineage tracing experiments have preliminarily shown that Scara5 + Cells promote the repair of alveolar bone damage; A: Section of the extraction side of the mandibular first molar 7 days after induction. The arc dotted line indicates the location of the extraction socket, and the dotted area in the box is magnified in (a1), (a2), (a3), and (a4). B: Section of the extraction side of the mandibular first molar 14 days after induction. The boxed area is magnified in (b1) and (b2).

[0024] Figure 9 shows H11ZsGreen-LSL-tdTomato, Scara5-Cre in the embodiment ERT2 Mouse lineage tracing experiments have preliminarily shown that Scara5 + Cells promote the repair of dental pulp damage; A: Pulp damage in the maxillary first molar 25 days after induction. The arc dotted line indicates the location of the damage, and the dotted area in the box is magnified in (a1); B: Sections of pulp damage in the maxillary first molar 25 days after induction. Sections at different positions are magnified in (b1); C: Sections of pulp damage in the maxillary first molar 25 days after induction. Sections at different positions are magnified in (c1) and (c2). DETAILED DESCRIPTION

[0025] The present invention is further described below with reference to specific examples, which are only used to illustrate the present invention and are not used to limit the scope of the present invention.

[0026] The following examples provide a dental tissue mesenchymal stem cell labeling system, which includes the Scara5 gene and the tdTomato reporter gene. This characteristic expression system is specifically expressed only in dental tissues (periodontal or dental pulp).

[0027] The following examples also provide a method for screening a subpopulation of dental mesenchymal stem cells, wherein dental tissue cells are sorted to obtain cells positive for the Scara5 marker, thereby obtaining a Scara5+ dental mesenchymal stem cell subpopulation.

[0028] The following examples also propose the use of cells that specifically express the Scara5 gene in the preparation of drugs for repairing odontogenic tissue damage, and lineage tracing to track Scara5 in vivo. + Cell subsets play a significant role in promoting the repair of periodontal tissue damage.

[0029] Example 1

[0030] 1. Methods

[0031] a. Based on single-cell sequencing analysis of human periodontal ligament, a new subpopulation of periodontal ligament mesenchymal stem cells was discovered, and the highly specific and sensitive marker gene Scara5 for this possible new subpopulation was identified.

[0032] ①Data analysis: Cell Normalization, Cell Clustering, RdsPlot analysis, ReCluster, Pseudotime analysis, GO analysis, Pathway Analysis, SCENIC (Single Cell Regulatory Network Inference and Clustering), QuSAGE analysis, Cell Phone Analysis, and ScGeneModule analysis.

[0033] b. Verify the expression ratio and localization of Scara5 in mouse and human periodontal ligament tissues

[0034] c. Construct CreER mice driven by the marker gene promoter of the candidate population for lineage tracing and cell elimination verification.

[0035] ① Modify the candidate marker gene using CRISPR / Cas9 technology and insert P2A-Cre before its stop codon ERT2 , obtained a tamoxifen-induced inducible conditional Cre expression mouse model, and constructed a CreER mouse driven by the Scara5 promoter of the candidate population.

[0036] ②Construction of an inducible conditional fluorescence expression mouse model: Scara5-Cre ERT2 Mice and R26 tdTomato After one generation of hybridization, mice expressing inducible conditional fluorescence were obtained.

[0037] ③Construction of an inducible cell elimination mouse model: Scara5-Cre ERT2 and R26 DTR (Rosa26-loxP-STOP-loxP-DTR) mice were mated to obtain cell knockout model mice.

[0038] ④ Based on tdtomato + Fluorescent labeling efficiency verified the successful construction of the mouse.

[0039] d. Analysis of Scara5 + The important role of cells in maintaining homeostasis of odontogenic tissues

[0040] ①Using inducible conditional fluorescent expression mice, Scara5 was analyzed by lineage tracing + The fate transition and functional effects of cell subsets on adult odontogenic tissue.

[0041] ② After 3 days of tamoxifen induction, the inducible conditional fluorescent expression mice were co-stained with β3-tubulin, EMCN, OPN, and POSTN primary antibodies to analyze Scara5 + The relationship between cell expression localization and blood vessels, nerves, fibroblasts and osteoblasts.

[0042] e. Research Scara5 + The important role of cells in the repair of odontogenic tissue damage

[0043] ① One week after the inducible fluorescent-labeled mice were injected with tamoxifen, tooth extraction injury models, periodontal-alveolar bone injury models, and dental pulp injury models were constructed and analyzed. The repair of the periodontal ligament and alveolar bone and the changes in the number of tdTomato+ cells in the periodontal ligament and alveolar bone were analyzed 7 days, 14 days, and 30 days after injury.

[0044] ②Tooth extraction injury model, periodontal-alveolar bone injury model and dental pulp injury model were constructed. Thirty days after injury, the cells were co-stained with β3-tubulin, EMCN, OPN and POSTN primary antibodies to analyze the repair of periodontal ligament and alveolar bone and the changes in the localization of tdTomato+ cells in periodontal ligament and alveolar bone.

[0045] f. Study Scara5 in the case of odontogenic tissue damage + Proliferative changes in cell lineages

[0046] ①Construct tooth extraction injury model and dental pulp injury model and inject Edu, analyze the periodontal ligament and alveolar bone repair and the Edu of periodontal ligament and alveolar bone 4, 10, 15 and 30 days after injury. + / dTomato + Changes in cell ratios.

[0047] g. Verify Scara5 + Effects of cell ablation on the homeostasis of periodontal ligament-alveolar bone tissue

[0048] ① Establish an inducible conditional knockout mouse model R26DTA, Scara5-CreERT2, inject tamoxifen into 4-week-old and 8-week-old mice to establish tooth extraction injury model and alveolar bone injury model;

[0049] ②Analysis of Scara5 + Changes in the damage and repair of periodontal ligament and alveolar bone tissue after cell removal;

[0050] ③Analysis of Scara5 + tdTomato in the periodontal ligament and alveolar bone after cell removal + Cell differentiation, co-staining with β3-tubulin, EMCN, OPN, and POSTN primary antibodies, and analysis of Scara5 + The relationship between cell expression localization and blood vessels, nerves, fibroblasts and osteoblasts.

[0051] 2. Results

[0052] (1) Using single-cell sequencing combined with bioinformatics analysis, we found that Scara5 + The cell subsets may be a group of key cell subsets:

[0053] ① Healthy premolars were collected from patients undergoing orthodontic tooth extraction. Single-cell suspensions of periodontal ligament tissue were isolated by enzymatic digestion and mechanical dissociation, and single-cell transcriptome sequencing was performed. Based on the single-cell sequencing data analysis, a single-cell atlas of the human periodontal ligament was constructed. Ten cell types, including fibroblasts, pericytes, endothelial cells, hemocytes, epithelial cells, osteoclasts, and macrophages, were identified using known markers (Figure 1.AB). A subpopulation (cluster 9) distinct from known cell populations was discovered. This subpopulation is located directly upstream of all fibroblasts in terms of three-dimensional structure and is connected to pericytes (Figure 1.C). This new population displays unique signature genes, including Scara5, Fbln2, Vcan, and Apod, but expresses no or low levels of terminal fibroblast markers, suggesting a potential precursor state for this subpopulation (Figure 1.DE).

[0054] ②Further focusing on cluster 9, we found that this subgroup specifically overexpressed the gene Scara5 (Figure 2.AB). +To explore the role and mechanism of cell subsets in the maintenance and remodeling of periodontal homeostasis, the expression ratio and localization of Scara5 in mouse and human periodontal ligament tissues were detected. It was found that Scara5 positive signals were located around the blood vessels of human periodontal ligament. The expression ratio and localization of Scara5 signals in mouse and human periodontal ligament tissues were consistent (Figure 2.CD).

[0055] ③ Further single-cell sequencing was used for pseudo-time series analysis to study the relationship between the identified fibroblast population and Scara5 + The phylogenetic relationships between subpopulations were analyzed and predicted using Scara5 + There are two differentiation trajectories starting from cell subpopulations, one fate is towards subpopulation 6, and the other fate is towards subpopulations 0, 1, 2, 3, 4, 9, and 10 (Figure 7.AC); further Beam (branch expression) analysis confirmed that Scara5 gene expression is in the pre-branch precursor state (Figure 7.D).

[0056] (2) To study the role of the Scara5+ subpopulation in maintaining odontogenic tissue homeostasis and tissue remodeling, a Scara5 promoter-driven inducible conditional Cre expression mouse (Scara5-CreERT2) lineage tracing research model was constructed:

[0057] The Scara5 gene was modified using CRISPR / Cas9 technology. Cas9, sgRNA, and donor were microinjected into fertilized eggs of C57BL / 6J mice for homologous recombination to construct Scara5 promoter-driven CreER mice. PCR and sequencing verification confirmed that the constructed positive F0 generation mice were mated with C57BL / 6J mice to obtain stably inherited positive Scara5-Cre ERT2 Mouse model (Figure 4.AD). ERT2 The mice were crossed with the conditional fluorescence expression mice H11ZsGreen-LSL-tdTomato mice to obtain the inducible conditional fluorescence expression mice H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 The expression of tdTomato protein in cells induced by Scara5 promoter activation was verified by injection of tamoxifen (Figure 4.E). Immunofluorescence staining showed that tdTomato + The cells are located around the periodontal ligament fibers and blood vessels of mice, and the signal expression ratio and location are similar to Scara5 + The above experiments all showed that H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 Lineage-tracing mice.

[0058] (3) Lineage tracing technology confirmed that Scara5 is poorly expressed throughout the body and does not participate in the tissue replacement of other fibroblastic connective tissues:

[0059] To track Scara5 in vivo + Cell fate, induction of adult Scara5-Cre ERT2 , H11ZsGreen-LSL-tdTomato mice. On the 35th day after induction, fluorescence observation was performed on the main fibroblast connective tissues throughout the body. The results showed that no large amount of red fluorescent signals were observed in the heart, kidneys, lungs and spleen after long-term tracing, indicating that scara5+ is not involved in the daily turnover and stability of tissues in these organs (Figure 5.Aa1-2, 3-6). In liver tissue, scara5+ cells are mainly located around the vascular system and do not participate in the formation of downstream liver cells. They may be closely related to blood vessels and veins, but do not participate in liver tissue homeostasis (Figure 5.Aa3).

[0060] (4) Tracking Scara5 through lineage tracing technology + The role and fate of cells in the homeostasis and remodeling of the periodontium, dental pulp, and alveolar bone indicate that Scara5 is a marker specifically expressed in odontogenic tissues:

[0061] To track Scara5 in vivo + Cell fate, induced by adult Scara5-Cre ERT2 , H11ZsGreen-LSL-tdTomato mice. 3 days after induction, positive cells were detected mainly in the apical PDL (Figure 6.A3-4), partially scattered in the alveolar bone marrow and dental pulp (Figure 6.A1-2), but not in the cementum or alveolar bone cells (Figure 6.A). 7 days after induction, Scara5 + The cells contributed 40% of the DP and proliferated extensively in the periodontal ligament at the root apex (Fig. 6.B); after 60 days of induction, Scara5 + Scara5 cells contributed 95% of the DP (Figure 6.C). The number of positive cells in the apical PDL increased over time and began to extend to the upper part of the root, but did not form the entire periodontal ligament tissue (Figure 6.C3-4). No significant changes were found in the number and distribution of positive cells in the alveolar bone (Figure 6.C1-2). With lineage tracing, Scara5 was not found in alveolar bone osteocytes and cementum. + Positive signal. The above results show that Scara5 + Cells are involved in the renewal and maintenance of homeostasis of odontogenic tissues.

[0062] (5) Establish a mouse periodontal ligament-alveolar bone puncture injury model and further study Scara5 using lineage tracing technology +The role and fate of cells in the repair of periodontal-alveolar bone damage:

[0063] Through inducible conditional fluorescent expression of mouse H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 , after continuous injection of tamoxifen for 2 days, a periodontal-alveolar bone injury model was constructed, and a slow machine was used to drill holes in the root bifurcation area of ​​the first molar. 14 days after injury, lineage tracing frozen section staining showed that compared with the control group B1, position A1 was damaged to the periodontal ligament and alveolar bone in the root bifurcation area, and obvious red fluorescent signals could be observed entering the damaged position and participating in tissue repair (Figure 7.A1-B1). 30 days after injury, the damaged area had been repaired and loose bone tissue had been formed (Figure 7.C1). Compared with the control group D-a1 and A1 14 days after injury, the red fluorescent signal increased significantly (Figure 7.C1-D1), indicating that scara5+ increased with time, and the greater the role played in the damage repair process, indicating that Scara5 + Cells are able to respond to periodontal injury signals and participate in periodontal ligament-alveolar bone remodeling under repair.

[0064] (6) Establish a mouse tooth extraction injury model and further study Scara5 using lineage tracing technology + The role and fate of cells in the repair process of alveolar bone injury:

[0065] Through inducible conditional fluorescent expression of mouse H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 After continuous injection of tamoxifen for 2 days, a mouse mandibular tooth extraction model was established. 7 days after tooth extraction, lineage tracing frozen section staining revealed a clear extraction socket, with a mixed arrangement of fuzzy structure-alveolar bone structure-fuzzy structure, corresponding to the distal root root repair-root bifurcation alveolar socket-mesial root after tooth extraction (Figure 8.A). Red fluorescent signals were scattered at the positions of the two roots. A surge in the number of red fluorescent cells was observed inside the extraction area, which aggregated in the alveolar socket. A large number of Scara5 +The cells are arranged in a fiber-like structure (Figure 8.A1-4); 14 days after tooth extraction, in the area near the second molar, irregularly arranged trabecular bone structures are clearly visible in the extraction socket, and bone pits and osteocytes buried in them can be seen in the bone matrix, indicating that new bone tissue has been generated. At this time, the trabeculae are thin in shape, with wide gaps, and the medullary cavity is mostly composed of unmineralized fibrous connective tissue. The outline of the extraction socket is still clear (Figure 8.B). 14 days after tooth extraction, the red fluorescence in the mesial area near the second molar increased significantly compared to 7 days after tooth extraction. Most of it coincided with the position of the irregular trabecular bone structure and was mostly located in the medullary cavity, but no obvious red fluorescence was found to be localized to the osteocytes. Therefore, scara5+ lineage cells play an important role in the healing of the alveolar bone extraction socket (Figure 8.B1-2).

[0066] (7) Establish a mouse dental pulp injury model and further study Scara5 using lineage tracing technology + The role and fate of cells in the repair process of dental pulp injury:

[0067] Through inducible conditional fluorescent expression of mouse H11ZsGreen-LSL-tdTomato, Scara5-Cre ERT2 , a mouse maxillary dental pulp injury model was constructed after continuous injection of tamoxifen for 2 days. 25 days after dental pulp injury, lineage tracing frozen section staining showed that the original crown pulp position was obviously damaged, while the root pulp showed obvious red fluorescence signal, indicating that scara5+ cells in the dental pulp responded to the crown pulp injury signal (Figure 9.AC). Careful observation of the root pulp signal distribution showed that compared with the steady state (Figure 6.C2), scara5+ entered from the fibroblast position in the center of the dental pulp to the outermost odontoblasts (Figure 8.A1-C2). The above data show that scara5 + Cell subpopulations and their lineages can respond to dental pulp injury and promote tissue damage repair by differentiating into downstream functional cells, odontoblasts, playing a key role in dental pulp injury and pulp disease.

[0068] The above is only a preferred embodiment of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and supplements without departing from the method of the present invention. These improvements and supplements should also be regarded as the scope of protection of the present invention.

Claims

1. The use of Scara5 as a biomarker of dental tissue mesenchymal stem cells, characterized in that: Scara5 is specifically expressed in the dental tissue mesenchymal stem cells.

2. The use according to claim 1, characterized in that: Scara5 is used to prepare a marker for dental tissue-derived mesenchymal stem cells.

3. The use according to claim 1 or 2, characterized in that: The odontogenic tissue includes periodontium, dental pulp and alveolar bone.

4. A Scara5+ dental mesenchymal stem cell subpopulation obtained by sorting dental tissue cells to obtain cells positive for the Scara5 marker.

5. Use of the Scara5+ dental mesenchymal stem cell subset according to claim 4 in the preparation of a drug for promoting the repair of dental tissue damage.

6. The use according to claim 5, characterized in that: The odontogenic tissue damage includes periodontal damage, dental pulp damage and alveolar bone damage.

7. Application of dental mesenchymal stem cells specifically expressing Scara5 in the preparation of drugs for promoting the repair of dental tissue damage.

8. The use according to claim 7, characterized in that: The odontogenic tissue damage includes periodontal damage, dental pulp damage and alveolar bone damage.

9. Application of dental mesenchymal stem cell subpopulations specifically expressing Scara5 in the preparation of stem cell drugs for periodontal disease, pulp disease, alveolar bone defect, alveolar bone resorption, and alveolar bone necrosis.

Citation Information

Patent Citations

  • Screening method and application of direct mechanical response cell subpopulation

    CN112029710A

  • Method for screening new subset of periodontal ligament specific stem cells based on single cell sequencing and application thereof

    CN112481364A

  • Application of Scara5 in preparation of medicine for promoting dental tissue damage repair

    CN116926202A

  • Novel dental stem cells from tooth follicles and the method for culturing them

    KR1020090033643A

  • Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    US20070009492A1